These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of diuretics in salt-retaining states. Hura CE; Kunau RT; Stein JH Semin Nephrol; 1988 Dec; 8(4):318-32. PubMed ID: 3068753 [No Abstract] [Full Text] [Related]
7. Treatment of nephrotic edema with bumetanide. Lemieux G; Beauchemin M; Gougoux A; Vinay P Can Med Assoc J; 1981 Nov; 125(10):1111-2, 1117. PubMed ID: 7034916 [TBL] [Abstract][Full Text] [Related]
10. [The treatment of hydropigenous syndromes with ethacrynic acid. (Apropos of 100 cases)]. Barjon P; Pelissier JG Sem Hop; 1967 Jan; 43(2):95-106. PubMed ID: 4291741 [No Abstract] [Full Text] [Related]
11. Efficacy of metolazone in patients with renal edema. Dargie HJ; Allison ME; Kennedy AC; Gray MJ Clin Nephrol; 1974; 2(4):157-60. PubMed ID: 4847130 [No Abstract] [Full Text] [Related]
12. Management of intractable edema in nephrotic syndrome. Glassock RJ Kidney Int Suppl; 1997 Mar; 58():S75-9. PubMed ID: 9067950 [No Abstract] [Full Text] [Related]
13. The use and abuse of diuretics. Francisco LL; Ferris TF Arch Intern Med; 1982 Jan; 142(1):28-32. PubMed ID: 7032445 [No Abstract] [Full Text] [Related]
14. Co-administration of albumin and furosemide in patients with the nephrotic syndrome. Hari P; Bagga A Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):371-2; author reply 372-3. PubMed ID: 22382243 [No Abstract] [Full Text] [Related]
15. [Indication and choice of diuretic treatment]. Plouin PF; Castaigne A; Francoual M Rev Prat; 1978 Nov; 28(51):3987-8, 3991-2, passim. PubMed ID: 741186 [No Abstract] [Full Text] [Related]
16. [The use of polyglucin (dextran) in the treatment of edema]. Eliseev OM Ter Arkh; 1966 Jun; 38(6):96-102. PubMed ID: 5988049 [No Abstract] [Full Text] [Related]
17. [Study of the clinical and metabolic effects of an inhibitor of kaliuresis, amipromyzide (MK 870)]. Guedon M; Cote M; Gay M J Urol Nephrol (Paris); 1968; 74(4):363-9. PubMed ID: 5675118 [No Abstract] [Full Text] [Related]
18. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Doucet A; Favre G; Deschênes G Pediatr Nephrol; 2007 Dec; 22(12):1983-90. PubMed ID: 17554565 [TBL] [Abstract][Full Text] [Related]
19. [Clinical trial of the salidiuretic clorexolone 12.833 R.P. (Flonatril)]. Mary P; Mirouze J Sem Ther; 1966 Nov; 42(9):529-32. PubMed ID: 5988528 [No Abstract] [Full Text] [Related]
20. [Results of treatment of nephrotic syndrome in children in the light of our cases]. Wyszyńska T Pediatr Pol; 1969 Sep; 44(9):1117-27. PubMed ID: 5364499 [No Abstract] [Full Text] [Related] [Next] [New Search]